GlassScriptPhysician profile
Dipak Jana
NPI 1629270731
$1,375.80
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $232 · 2022: $118 · 2023: $454 · 2024: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854 · Consulting Fee: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.23 |
| Consulting Fee | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $297.67 | 2022-2024 | Lifevest |
| Amgen INC. | $210.34 | 2019-2024 | Repatha |
| Edwards Lifesciences Corporation | $145.89 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $128.01 | 2020-2024 | |
| Bardy Diagnostics, INC. | $125.00 | 2019-2020 | |
| Boston Scientific Corporation | $82.59 | 2024 | Latitude Communicator Power Supply |
| Kiniksa Pharmaceuticals International, Plc | $72.45 | 2024 | Arcalyst |
| Abbott Laboratories | $56.49 | 2019-2020 | |
| Philips North America LLC | $53.90 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $50.52 | 2024 | Farxiga |
| Sanofi-Aventis U.S. LLC | $36.13 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $27.23 | 2020 | |
| Atricure, INC. | $21.56 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $19.23 | 2023 | Livalo |
| Irhythm Technologies, INC. | $17.18 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $16.61 | 2024 | Flexitouch Plus, Entre Plus |
| Baxter Healthcare | $15.00 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipak Jana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.